Search

Jun Inoue

from Woodland Hills, CA
Age ~61
Get Report
Related to:
Junko InoueYusuke Inoue, 56Yusuke Inoue
Connected to:
Akira Inoue, 65Andrea Y Inoue, 27Asuka Inoue, 44Carolina Y Inoue, 35Chikako Inoue, 51Chizuru G Inoue, 47Guilherme K Inoue, 38Hana Inoue, 49Haruhiko Inoue, 62Hideyuki Inoue, 58

Jun Inoue Phones & Addresses

  • Woodland Hills, CA
  • Burbank, CA
  • 5901 Montrose Rd, Rockville, MD 20852

Work

Company: Senju-usa inc. Apr 2008 Position: Vice president

Education

Degree: Doctorates, Doctor of Philosophy School / High School: The University of Tokushima 2004 to 2004 Specialities: Chemistry

Skills

Drug Development • Drug Discovery • Life Sciences • Pharmaceutical Industry • Pharmacology • Drug Delivery • Hplc • Medicinal Chemistry • Biotechnology • Biopharmaceuticals • Technology Transfer • Organic Chemistry • Chemistry • Glaucoma • Pharmaceutics • Clinical Trials • High Performance Liquid Chromatography • Lifesciences

Industries

Pharmaceuticals

Resumes

Resumes

Jun Inoue Photo 1

Vice President

View page
Location:
Woodland Hills, CA
Industry:
Pharmaceuticals
Work:
Senju-Usa Inc.
Vice President
Education:
The University of Tokushima 2004 - 2004
Doctorates, Doctor of Philosophy, Chemistry University of Kindai Himeji 1982 - 1986
Skills:
Drug Development
Drug Discovery
Life Sciences
Pharmaceutical Industry
Pharmacology
Drug Delivery
Hplc
Medicinal Chemistry
Biotechnology
Biopharmaceuticals
Technology Transfer
Organic Chemistry
Chemistry
Glaucoma
Pharmaceutics
Clinical Trials
High Performance Liquid Chromatography
Lifesciences

Publications

Us Patents

Ophthalmic Composition

View page
US Patent:
8211450, Jul 3, 2012
Filed:
May 5, 2010
Appl. No.:
12/774419
Inventors:
Jun Inoue - Woodland Hills CA, US
Tapan Shah - Woodland Hills CA, US
Assignee:
Senju USA, Inc. - Woodland Hills CA
International Classification:
A61K 9/00
US Classification:
424400
Abstract:
The present invention provides an ophthalmic composition comprising a hyperbranched polymer. The ophthalmic compositions may also comprise carbonic anhydrase inhibitors, wherein the hyperbranched polymer increases the aqueous solubility of the carbonic anhydrase inhibitor, and increases corneal permeation of the active agent. The ophthalmic compositions may also comprise non-ionic surfactants, such as polysorbate, hydroxypropyl methyl cellulose or hydroxyethyl cellulose, and beta-blockers, such as carteolol, levobunolol, betaxolol, metipranolol, timolol or propranolol.

Ophthalmic Composition

View page
US Patent:
20130053374, Feb 28, 2013
Filed:
May 4, 2011
Appl. No.:
13/695930
Inventors:
Jun Inoue - Woodland Hills CA, US
Tapan Shah - Woodland Hills CA, US
International Classification:
A61K 47/34
A61K 31/382
A61P 27/02
A61K 47/38
A61K 47/22
A61K 31/5377
C07C 211/02
A61K 31/542
US Classification:
5142265, 564512, 514788, 514432, 514781, 514785, 5142362
Abstract:
The present invention provides an ophthalmic composition comprising a hyperbranched polyester. The ophthalmic compositions may also comprise carbonic anhydrase inhibitors, wherein the hyperbranched polyester increases the aqueous solubility of the carbonic anhydrase inhibitor, and increases corneal permeation of the active agent. The ophthalmic compositions may also comprise non-ionic surfactants, such as PEG, Polysorbate, HPMC or HEC, and beta-blockers, such as Carteolol, Levobunolol, Betaxolol, Metipranolol, Timolol or Propranolol. The concentration of the hyperbranched polyester in the ophthalmic formulation should be less than or equal to 4% (w/v) in order to avoid any cytotoxic effects on human corneal cells and thus the eye irritation.
Control profile
Jun Inoue from Woodland Hills, CA, age ~61 Get Report